A phase I/II study of bortezomib in combination with paclitaxel, carboplatin, and concurrent thoracic radiation therapy for non-small-cell lung cancer: North Central Cancer Treatment Group (NCCTG)-N0321

Yujie Zhao, Nathan R. Foster, Jeffrey P. Meyers, Sachdev P. Thomas, Donald W. Northfelt, Kendrith M. Rowland, Bassam I. Mattar, David B. Johnson, Julian R. Molina, Sumithra J. Mandrekar, Steven E. Schild, James D. Bearden, Marie Christine Aubry, Alex A. Adjei

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A phase I/II study of bortezomib in combination with paclitaxel, carboplatin, and concurrent thoracic radiation therapy for non-small-cell lung cancer: North Central Cancer Treatment Group (NCCTG)-N0321'. Together they form a unique fingerprint.

Medicine & Life Sciences